| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/05/2004 | CA2492542A1 Oligodendrocyte production from multipotent neural stem cells |
| 02/05/2004 | CA2492424A1 Sustained-release tablet comprising reboxetine |
| 02/05/2004 | CA2492210A1 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 02/05/2004 | CA2489165A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 02/05/2004 | CA2488860A1 Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former |
| 02/05/2004 | CA2401567A1 Methods of preventing the inhibition of apoptosis and treating inflammatory conditions |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386920A1 Benzimidazolone derivatives |
| 02/04/2004 | EP1386919A1 Remedies |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1386908A1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 02/04/2004 | EP1386613A1 Compositions for preparing external carbon dioxide agents |
| 02/04/2004 | EP1386612A1 Drugs fo rpromoting the proliferation, differentiation and/or survival of glial cells containing cyclic phosphatidic acid |
| 02/04/2004 | EP1386607A1 Process for the preparation of Donepezil |
| 02/04/2004 | EP1386605A1 Improved transdermal delivery system for the administration of rotigotine |
| 02/04/2004 | EP1386604A1 Improved transdermal delivery system |
| 02/04/2004 | EP1386166A2 Anti-epileptogenic agents |
| 02/04/2004 | EP1386155A2 Therapeutic and diagnostic uses of antibody specificity profiles |
| 02/04/2004 | EP1385993A2 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 02/04/2004 | EP1385980A2 Yeast strains autonomously producing steroids |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385966A2 Recombinant fusion proteins and the trimers thereof |
| 02/04/2004 | EP1385958A2 Human tachykinin-related splice variants and compositions thereof |
| 02/04/2004 | EP1385952A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 02/04/2004 | EP1385945A1 Novel mutation |
| 02/04/2004 | EP1385938A1 Method and culture medium for producing neural cells expressing tyrosine hydroxylase |
| 02/04/2004 | EP1385937A1 Delivery of polynucleotide agents to the central nervous sysstem |
| 02/04/2004 | EP1385934A2 Pufa polyketide synthase systems and uses thereof |
| 02/04/2004 | EP1385884A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385878A2 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 02/04/2004 | EP1385874A1 Alpha conotoxin peptides with analgesic properties |
| 02/04/2004 | EP1385873A2 A ligand for enhancing oral and cns delivery of biological agents |
| 02/04/2004 | EP1385857A1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
| 02/04/2004 | EP1385842A1 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385840A1 Sulfonamides |
| 02/04/2004 | EP1385839A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385831A2 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
| 02/04/2004 | EP1385830A1 Sulfonamides |
| 02/04/2004 | EP1385827A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents |
| 02/04/2004 | EP1385825A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 02/04/2004 | EP1385824A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 02/04/2004 | EP1385822A1 Aminopyrrolidine sulfonamides as serine protease inhibitors |
| 02/04/2004 | EP1385550A2 Therapeutic method for inducing tolerance |
| 02/04/2004 | EP1385544A2 Humanized antibodies |
| 02/04/2004 | EP1385536A2 Preparations containing a combination of vitamin e and afamin |
| 02/04/2004 | EP1385533A1 Module of pd-1 interactions with its ligands |
| 02/04/2004 | EP1385531A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | EP1385523A2 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment |
| 02/04/2004 | EP1385520A2 Methods and compounds for the treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
| 02/04/2004 | EP1385518A1 Benzimidazolone compounds |
| 02/04/2004 | EP1385517A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 02/04/2004 | EP1385515A1 Spiropyrazole compounds |
| 02/04/2004 | EP1385514A1 Spiroindene and spiroindane compounds |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1385507A1 Sulfonamides |
| 02/04/2004 | EP1385503A1 The use of enantiomeric pure escitalopram |
| 02/04/2004 | EP1385500A1 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 02/04/2004 | EP1385495A2 Sulfonamides |
| 02/04/2004 | EP1385493A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties |
| 02/04/2004 | EP1385490A1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins |
| 02/04/2004 | EP1385484A2 Compositions and methods of manufacture for oral dissolvable dosage forms |
| 02/04/2004 | EP1385476A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 02/04/2004 | EP1385459A2 Transdermal delivery of pergolide |
| 02/04/2004 | EP1185291B1 Therapeutic agent comprising a botulinum neurotoxin |
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | EP1076650B1 Aryl fused azapolycyclic compounds |
| 02/04/2004 | EP0938333B1 Method of enhancing the delivery of growth factors |
| 02/04/2004 | EP0925067B1 Graft from submucosal intestinal tissue for repairing neurological tissue |
| 02/04/2004 | EP0698094B1 Bmp-11 compositions |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473158A Radiopharmaceuticals for diagnosing alzheimer's disease |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1473144A Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride |
| 02/04/2004 | CN1473050A Use of long pentraxin PTX3 for treatment of diseases caused by altered activation of growth factor FGF-2 |
| 02/04/2004 | CN1473048A 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 02/04/2004 | CN1473047A Method for treating hypogonadism |
| 02/04/2004 | CN1473045A Process for preparation of dinapsoline |
| 02/04/2004 | CN1471954A Chinese medicine for withdrawal of drug dependence |
| 02/04/2004 | CN1471940A Reed rhizome sophorae decoction |
| 02/04/2004 | CN1471936A Apoplexia hemiplegic recovered capsule and preparing method thereof |
| 02/04/2004 | CN1471917A Western medicine vitamin mixture for Meniere's disease |
| 02/04/2004 | CN1471909A High-capacitance |
| 02/04/2004 | CN1137125C Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 02/04/2004 | CN1137123C Azolo triazizes and pyrimidines |
| 02/04/2004 | CN1137097C Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors |
| 02/04/2004 | CN1137083C New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/04/2004 | CN1136847C Application of isogorgonian acid in pharmacy |
| 02/04/2004 | CN1136838C Solid, quick dissolving cetirizine fomulation |
| 02/03/2004 | US6686473 Process for the production of paroxetine |
| 02/03/2004 | US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 02/03/2004 | US6686377 For therapy of pain |
| 02/03/2004 | US6686374 Azaindoles having serotonin receptor affinity |
| 02/03/2004 | US6686373 Analgesics; antiinflammatory agent |
| 02/03/2004 | US6686372 Selective β3 adrenergic agonists |